Larson Financial Group’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-3
Closed -$141 3496
2025
Q3
$141 Buy
3
+1
+50% +$52 ﹤0.01% 3290
2025
Q2
$104 Sell
2
-1
-33% -$55 ﹤0.01% 3159
2025
Q1
$181 Hold
3
﹤0.01% 2811
2024
Q4
$205 Hold
3
﹤0.01% 2433
2024
Q3
$216 Hold
3
﹤0.01% 2349
2024
Q2
$208 Buy
+3
New +$219 ﹤0.01% 2051

Other funds holding CNMD

Larson Financial Group's CNMD Position: Q4 2025 in Review

Larson Financial Group sold out of CONMED (CNMD) in Q4 2025, closing a stake of 3 shares — an estimated $141 sold.

Larson Financial Group first reported a position in CNMD in Q2 2024 and held it in 6 quarters. The position peaked at $216 in Q3 2024. 265 funds tracked by Wall St. Rank hold CNMD as of Q4 2025.

  • Larson Financial Group reported no remaining CONMED position as of Q4 2025 after selling out during the quarter.
  • Larson Financial Group sold 3 CONMED shares in Q4 2025, an estimated $141.
  • Larson Financial Group first reported a position in CONMED in Q2 2024 and held it in 6 quarters.
  • Larson Financial Group's CONMED position peaked at $216 in Q3 2024.
  • 265 funds tracked by Wall St. Rank held CONMED as of Q4 2025.

Based on Larson Financial Group's 13F filing for Q4 2025, filed 6 Feb 2026.